Enter your information to understand your LDL levels.

The History of LDL Cholesterol

American scientist John Gofman first pioneered lipoprotein research at Berkeley during the early 1950s, using a powerful ultracentrifuge to separate blood cholesterol into distinct density-based classes, revealing for the very first time that the particle now known as LDL carried the vast majority of circulating cholesterol and correlated strongly with underlying cardiovascular disease risk. For decades afterward, actually measuring LDL directly remained technically difficult and expensive, limiting its routine use in ordinary clinical practice despite its clear and steadily growing scientific importance to doctors. That changed dramatically in 1972, when researcher William Friedewald published a simple mathematical formula allowing LDL to be calculated indirectly from three far more easily measured values, total cholesterol, HDL cholesterol, and triglycerides, instantly making routine LDL testing practical and affordable for laboratories everywhere around the country and beyond.

What LDL Cholesterol Actually Is

LDL, or low-density lipoprotein, is a particle that carries cholesterol away from the liver out to cells throughout the body that genuinely need it for building cell membranes and producing certain essential hormones. When too much LDL circulates in the bloodstream, however, these particles can penetrate damaged or inflamed artery walls directly, gradually depositing cholesterol there and contributing directly to the dangerous plaque buildup process known as atherosclerosis, which is precisely why LDL has earned its now widely recognized nickname, "bad cholesterol." Unlike HDL, which actively removes cholesterol from tissues, LDL primarily delivers it outward, meaning consistently elevated LDL levels sustained over many years substantially raise the long-term risk of heart attack, stroke, and other cardiovascular events.

How LDL Cholesterol Is Measured

LDL has traditionally been calculated using the Friedewald equation, subtracting HDL cholesterol and one-fifth of triglycerides from total cholesterol, a formula that works reasonably well for most ordinary patients but grows notably less accurate whenever triglyceride levels climb especially high. To address that specific known limitation, many modern laboratories now instead use direct enzymatic homogeneous assays, which measure LDL cholesterol directly in the blood sample without relying on any calculated estimate at all, offering meaningfully improved accuracy for patients with elevated triglycerides or certain other genuinely unusual lipid patterns. Both approaches remain widely used today, with laboratories generally choosing whichever specific method best fits each individual patient's particular clinical circumstances and their existing overall lipid profile.

Scientists Behind the Science

John Gofman's pioneering ultracentrifugation research in the early 1950s gave the scientific world its very first meaningful understanding of LDL as a genuinely distinct, clinically significant lipoprotein particle, laying the essential groundwork for everything cardiovascular medicine would eventually build directly upon it. William Friedewald's elegant 1972 mathematical calculation then transformed that early scientific insight into an immediately practical, everyday clinical reality, making LDL testing readily accessible and genuinely affordable for ordinary patients in ordinary laboratories worldwide almost overnight. Together, their combined contributions, separated by roughly two decades of steady scientific progress, turned LDL cholesterol into one of the single most consequential and closely monitored laboratory values in all of modern cardiovascular medicine practiced worldwide today.